Humana Inc (NYSE:HUM) Position Raised by First Quadrant L P CA

First Quadrant L P CA raised its stake in Humana Inc (NYSE:HUM) by 7.1% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 2,669 shares of the insurance provider’s stock after buying an additional 178 shares during the quarter. First Quadrant L P CA’s holdings in Humana were worth $682,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of HUM. Janney Montgomery Scott LLC raised its stake in shares of Humana by 3.5% during the second quarter. Janney Montgomery Scott LLC now owns 2,871 shares of the insurance provider’s stock valued at $762,000 after purchasing an additional 98 shares in the last quarter. FNY Investment Advisers LLC bought a new stake in shares of Humana during the second quarter valued at about $185,000. Morgan Stanley raised its stake in shares of Humana by 16.2% during the second quarter. Morgan Stanley now owns 289,736 shares of the insurance provider’s stock valued at $76,866,000 after purchasing an additional 40,376 shares in the last quarter. Advisor Group Inc. raised its stake in shares of Humana by 8.3% during the second quarter. Advisor Group Inc. now owns 4,913 shares of the insurance provider’s stock valued at $1,303,000 after purchasing an additional 377 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D raised its stake in shares of Humana by 37.5% during the second quarter. State of New Jersey Common Pension Fund D now owns 110,000 shares of the insurance provider’s stock valued at $29,183,000 after purchasing an additional 30,000 shares in the last quarter. Institutional investors own 92.78% of the company’s stock.

A number of equities research analysts recently weighed in on HUM shares. ValuEngine upgraded shares of Humana from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Canaccord Genuity restated a “buy” rating on shares of Humana in a research note on Monday, October 21st. Piper Jaffray Companies lifted their price objective on shares of Humana from $315.00 to $341.00 and gave the company an “overweight” rating in a research note on Thursday, August 1st. Deutsche Bank initiated coverage on shares of Humana in a research report on Thursday, September 12th. They issued a “hold” rating and a $300.00 price target on the stock. Finally, Berenberg Bank reiterated a “buy” rating on shares of Humana in a research report on Monday, October 21st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and sixteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $333.30.

In related news, insider Brian P. Leclaire sold 7,239 shares of Humana stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $289.70, for a total value of $2,097,138.30. Following the transaction, the insider now owns 12,994 shares of the company’s stock, valued at approximately $3,764,361.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.54% of the company’s stock.

Shares of HUM opened at $289.37 on Tuesday. The business’s 50-day moving average price is $272.19 and its 200 day moving average price is $268.09. The stock has a market capitalization of $38.72 billion, a P/E ratio of 19.89, a P/E/G ratio of 1.23 and a beta of 0.83. Humana Inc has a 1-year low of $225.65 and a 1-year high of $355.88. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 0.37.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.05 earnings per share for the quarter, topping the Zacks’ consensus estimate of $5.24 by $0.81. The firm had revenue of $16.25 billion for the quarter, compared to analysts’ expectations of $15.88 billion. Humana had a return on equity of 22.47% and a net margin of 4.13%. Humana’s revenue was up 13.9% on a year-over-year basis. During the same quarter last year, the business posted $3.96 EPS. On average, research analysts predict that Humana Inc will post 17.67 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.55 dividend. The ex-dividend date is Monday, December 30th. This represents a $2.20 dividend on an annualized basis and a yield of 0.76%. Humana’s dividend payout ratio is currently 15.12%.

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Story: What is a death cross?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.